文献速递认知障碍与痴呆

载脂蛋白E与脑脊液tau水平的性别特异性关联

Sex-Specific Association of Apolipoprotein E With Cerebrospinal Fluid Levels of Tau.
PubMed 文献 · JAMA Neurol · 2018-01-01

这项多队列研究纳入10个纵向队列,分析APOE与脑脊液β-淀粉样蛋白42、总tau、磷酸化tau及尸检神经原纤维缠结和神经炎性斑块的关系,发现APOE-ε4与脑脊液tau的关联在女性中强于男性,而与尸检神经原纤维缠结无性别差异。

要点

  • APOE-ε4与脑脊液总tau和磷酸化tau的关联在女性中强于男性。
  • 该性别差异仅在淀粉样蛋白阳性个体中观察到,淀粉样蛋白阴性个体中未观察到。
  • APOE与脑脊液β-淀粉样蛋白42、神经炎性斑块负荷或神经原纤维缠结负荷的关联无性别差异。

核心结论

  • 多个独立数据集提供有力证据表明,APOE-ε4与脑脊液tau水平的关联在女性中强于男性。
  • APOE-ε4与尸检神经原纤维缠结测量无差异性关联。
  • APOE可能以性别特异性方式调节神经变性风险,尤其在存在淀粉样变时。

研究设计与样本

  • 多队列研究,选自10个正常衰老和阿尔茨海默病的纵向队列研究。
  • 队列招募标准和随访间隔各异,包括人群样本和门诊样本。
  • 纳入分析需有APOE基因型数据和可分析的脑脊液数据。
  • 分析开始于2017年11月6日,完成于2017年12月20日。

主要发现

  • 脑脊液生物标志物队列1798例中,女性862例,阿尔茨海默病226例,白人1690例,平均(SD)年龄70(9)岁。
  • 尸检队列5109例中,女性2813例,白人4953例,平均(SD)年龄84(9)岁。
  • 经Bonferroni校正多重比较后,APOE-ε4与性别对脑脊液总tau存在显著交互作用(β=0.41;95%CI,0.27-0.55;P<.001),对磷酸化tau存在显著交互作用(β=0.24;95%CI,0.09-0.38;P=.001),APOE在女性中关联更强。
  • 事后分析提示该性别差异存在于淀粉样蛋白阳性个体(β=0.41;95%CI,0.20-0.62;P<.001),而在淀粉样蛋白阴性个体中不存在(β=0.06;95%CI,-0.18至0.31;P=.62)。
  • 未观察到APOE与脑脊液β-淀粉样蛋白42、神经炎性斑块负荷或神经原纤维缠结负荷关联的性别差异。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: The strongest genetic risk factor for Alzheimer disease (AD), the apolipoprotein E (APOE) gene, has a stronger association among women compared with men. Yet limited work has evaluated the association between APOE alleles and markers of AD neuropathology in a sex-specific manner. OBJECTIVE: To evaluate sex differences in the association between APOE and markers of AD neuropathology measured in cerebrospinal fluid (CSF) during life or in brain tissue at autopsy. DESIGN, SETTING, AND PARTICIPANTS: This multicohort study selected data from 10 longitudinal cohort studies of normal aging and AD. Cohorts had variable recruitment criteria and follow-up intervals and included population-based and clinic-based samples. Inclusion in our analysis required APOE genotype data and either CSF data available for analysis. Analyses began on November 6, 2017, and were completed on December 20, 2017. MAIN OUTCOMES AND MEASURES: Biomarker analyses included levels of β-amyloid 42, total tau, and phosphorylated tau measured in CSF. Autopsy analyses included Consortium to Establish a Registry for Alzheimer's Disease staging for neuritic plaques and Braak staging for neurofibrillary tangles. RESULTS: Of the 1798 patients in the CSF biomarker cohort, 862 were women, 226 had AD, 1690 were white, and the mean (SD) age was 70 [9] years. Of the 5109 patients in the autopsy cohort, 2813 were women, 4953 were white, and the mean (SD) age was 84 (9) years. After correcting for multiple comparisons using the Bonferroni procedure, we observed a statistically significant interaction between APOE-ε4 and sex on CSF total tau (β = 0.41; 95% CI, 0.27-0.55; P < .001) and phosphorylated tau (β = 0.24; 95% CI, 0.09-0.38; P = .001), whereby APOE showed a stronger association among women compared with men. Post hoc analyses suggested this sex difference was present in amyloid-positive individuals (β = 0.41; 95% CI, 0.20-0.62; P < .001) but not among amyloid-negative individuals (β = 0.06; 95% CI, -0.18 to 0.31; P = .62). We did not observe sex differences in the association between APOE and β-amyloid 42, neuritic plaque burden, or neurofibrillary tangle burden. CONCLUSIONS AND RELEVANCE: We provide robust evidence of a stronger association between APOE-ε4 and CSF tau levels among women compared with men across multiple independent data sets. Interestingly, APOE-ε4 is not differentially associated with autopsy measures of neurofibrillary tangles. Together, the sex difference in the association between APOE and CSF measures of tau and the lack of a sex difference in the association with neurofibrillary tangles at autopsy suggest that APOE may modulate risk for neurodegeneration in a sex-specific manner, particularly in the presence of amyloidosis.

来源:JAMA Neurol,查看原文。版权归原作者所有。

引用

  1. Hohman TJ, Dumitrescu L, Barnes LL, et al. Sex-Specific Association of Apolipoprotein E With Cerebrospinal Fluid Levels of Tau. JAMA Neurol. 2018. PMID: 29801024. doi:10.1001/jamaneurol.2018.0821

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。